Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
FANCA Antibody, FA1 Antibody, FACA Antibody, FA-H Antibody, Fanconi anemia group A protein Antibody, Fanconi anemia, type 1 Antibody, FA Antibody, Protein FACA Antibody, FAA Antibody, FANCH Antibody
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair.
FANCA Antibody -Lane 1: The Fanconi anemia core complex was obtained by IP from HeLa nuclear extracts with anti-FANCA under high stringency washing conditions, removing BLM, Topo III alpha, BLAP75 and RPA70 as indicated. Lane 2: BRAFT complex components immunoprecipitated by anti-FANCA.
Requested From: United States
Date Requested: 2/23/2017